September 28, 2016 1:40 AM ET

Healthcare Equipment and Supplies

Company Overview of NeoChord, Inc.

Company Overview

NeoChord, Inc., a medical device company, develops devices to treat mitral regurgitation. The company offers NeoChord, a disposable device that replaces damaged chordae through a small incision while the heart is beating. Its products are used to treat patients in TACT registry and non-registry centers in Europe. The company was founded in 2007 and is based in St. Louis Park, Minnesota.

5402 Parkdale Drive

Suite 160

St. Louis Park, MN 55416

United States

Founded in 2007





Key Executives for NeoChord, Inc.

Chief Executive Officer and President
Age: 49
Chief Financial Officer
Chief Medical Officer
Director of Quality
Vice President of Clinical Affairs, Regulatory and Quality
Age: 57
Compensation as of Fiscal Year 2016.

NeoChord, Inc. Key Developments

NeoChord Receives FDA Approval to Begin Clinical Trial for Treatment of Degenerative Mitral Valve Regurgitation

NeoChord, Inc. announced that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) to begin a prospective, multicenter, randomized clinical trial for its Artificial Chordae Delivery System, DS1000.

Neochord, Inc. Appoints Alex Jonkers as Vice President of Commercial Sales in Europe

NeoChord, Inc. announced the appointment of Alex Jonkers as Vice President of Commercial Sales in Europe. Most recently, Jonkers was with Medtronic, Inc.

NeoChord Appoints J. Alex Martin to its Board of Directors

NeoChord announced the appointment of J. Alex Martin to its Board of Directors. A 40-year, veteran corporate executive of the healthcare and medical device industries, Mr. Martin brings a proven track record for growing corporate revenue and successfully transforming global businesses. Most recently, Mr. Martin was the President and CEO of Coherex Medical, where he led the company to a successful exit with Biosense Webster in November 2015. Prior to Coherex, Mr. Martin was the President and CEO of WorldHeart Corporation, where he led the company to a successful exit with HeartWare in August 2012. Previously, Mr. Martin has held senior leadership roles with Edwards Lifesciences, Cordis Corporation and SonaMed Corporation.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NeoChord, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at